Financial Ratios

ISHITA DRUGS & INDUSTRIES LTD.

NSE : NABSE : 524400ISIN CODE : INE806D01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE69.75-1.84 (-2.57 %)
PREV CLOSE ( ) 71.59
OPEN PRICE ( ) 69.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6213
TODAY'S LOW / HIGH ( )69.00 71.85
52 WK LOW / HIGH ( ) 46.0198.37
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.932.692.771.831.18
   CEPS(Rs)2.363.133.262.421.70
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)30.6828.7526.0523.2821.45
   Tax Rate(%)25.9222.8221.2723.3124.05
Margin Ratios
   Core EBITDA Margin(%)6.317.746.585.155.68
   EBIT Margin(%)6.907.587.785.045.76
   Pre Tax Margin(%)6.467.407.554.815.09
   PAT Margin (%)4.785.715.953.693.87
   Cash Profit Margin (%)5.856.637.004.895.58
Performance Ratios
   ROA(%)5.107.858.826.124.54
   ROE(%)6.509.8211.258.185.64
   ROCE(%)8.9013.0014.3910.798.17
   Asset Turnover(x)1.071.371.481.661.17
   Sales/Fixed Asset(x)2.593.012.943.131.98
   Working Capital/Sales(x)1.481.902.132.621.79
Efficiency Ratios
   Fixed Capital/Sales(x)0.390.330.340.320.51
   Receivable days35.4126.7637.0930.6540.20
   Inventory Days38.8821.0916.1616.2429.30
   Payable days62.0654.3951.3152.3355.62
Valuation Parameters
   PER(x)25.5915.3610.815.9812.46
   PCE(x)20.9113.239.194.528.63
   Price/Book(x)1.611.441.150.470.68
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.020.550.460.170.39
   EV/Core EBITDA(x)12.796.425.262.775.26
   EV/EBIT(x)14.787.205.973.436.83
   EV/CE(x)1.080.680.700.270.43
   M Cap / Sales1.220.880.640.220.48
Growth Ratio
   Net Sales Growth(%)-14.321.01-5.9563.2234.15
   Core EBITDA Growth(%)-19.63-2.7833.0536.2518.79
   EBIT Growth(%)-21.97-1.6445.0842.9320.11
   PAT Growth(%)-28.27-2.9751.6455.6241.87
   EPS Growth(%)-28.27-2.9751.6455.6241.87
Financial Stability Ratios
   Total Debt/Equity(x)0.100.000.010.040.03
   Current Ratio(x)5.033.825.583.273.91
   Quick Ratio(x)4.243.455.123.033.49
   Interest Cover(x)15.5543.4234.3121.568.64
   Total Debt/Mcap(x)0.060.000.000.090.05

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.